TerminatedNot applicableNCT01356420
Sterol and Isoprenoid Disease Research Consortium: Smith-Lemli-Opitz Syndrome
Studying 46,XY difference of sex development due to a cholesterol synthesis defect
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Oregon Health and Science University
- Principal Investigator
- Robert Steiner, MDUniversity of Wisconsin, Madison
- Intervention
- Cholesterol supplementation(dietary_supplement)
- Enrollment
- 21 enrolled
- Eligibility
- 85 years · All sexes
- Timeline
- 2011 – 2015
Study locations (5)
- Pdgen, Nichd, Nih, Dhhs, Bethesda, Maryland, United States
- University of Nebraska Medical Center, Omaha, Nebraska, United States
- Cincinnati Children'S Hospital Medical Center, Cincinnati, Ohio, United States
- Oregon Health and Science University, Portland, Oregon, United States
- Children'S Hospital of Pittsburgh of Upmc, Pittsburgh, Pennsylvania, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01356420 on ClinicalTrials.gov